Hypertension
Secondary Hypertension
Identify secondary hypertension when presentation, treatment resistance, or target-organ injury suggests a remediable cause; confirm true resistance, remove iatrogenic contributors, then prioritize renal disease, primary aldosteronism, obstructive sleep apnea, renovascular disease, and selected endocrine disorders.
First decision
Identify presentations that warrant a secondary-cause pathway
Escalate beyond routine primary-hypertension management when the phenotype implies a reversible cause or immediate end-organ risk.
Prioritize a secondary-hypertension evaluation in patients younger than 40 years, those with sudden worsening or accelerated hypertension, and those with blood pressure that responds poorly to treatment. Accelerated hypertension with blood pressure above 180/110 mm Hg plus papilledema and/or retinal hemorrhage requires urgent assessment rather than deferred outpatient etiologic testing. nice org uk+1nice org ukNATIONAL INSTITUTE FOR HEALTH AND CLINICAL ...AHA JournalsPrevalence and Risk Factors for Secondary Hypertension ...
For severe blood-pressure elevation, first determine whether acute end-organ damage is present and obtain renal function, electrolytes, bicarbonate, glucose, HbA1c, lipids, complete blood count, clotting studies when microangiopathic hemolytic anemia or disseminated intravascular coagulation is a concern, urine microscopy, urine albumin-to-creatinine ratio, and thyroid function tests. NatureNatureManagement of hypertensive crisis: British and Irish ...
During a hypertensive crisis, collect endocrine studies selectively and interpret them cautiously. Pressure natriuresis with volume depletion can produce secondary hyperaldosteronism, while medications, pain, anxiety, subarachnoid hemorrhage-related stress, heart failure, and kidney failure can make renin, aldosterone, and metanephrine results unreliable; complete elective secondary-cause testing after stabilization when possible. NatureNatureManagement of hypertensive crisis: British and Irish ...
Use immediate plasma and/or urinary metanephrines when the clinical phenotype raises concern for pheochromocytoma or paraganglioma. NatureNatureManagement of hypertensive crisis: British and Irish ...
Obtain aldosterone and renin before starting drugs likely to complicate interpretation when primary aldosteronism is under active consideration and the patient is clinically stable enough for testing. NatureNatureManagement of hypertensive crisis: British and Irish ...
Do not delay urgent evaluation of suspected pheochromocytoma because it is potentially life-threatening and definitive management is tumor resection. nice org uknice org ukNATIONAL INSTITUTE FOR HEALTH AND CLINICAL ...
| Clinical trigger | Priority diagnostic direction | Immediate next action |
|---|---|---|
| Hypertension before age 40 years | Broad secondary-cause screen | Evaluate renal, renovascular, endocrine, sleep-related, and drug-induced contributors. ScienceDirect+1ScienceDirectEvaluations of secondary hypertension and laboratory data in the elderly populationAHA JournalsPrevalence and Risk Factors for Secondary Hypertension ... |
| Accelerated hypertension or BP >180/110 mm Hg with papilledema or retinal hemorrhage | Acute end-organ injury and secondary causes | Urgently assess renal, hematologic, urinary, metabolic, and thyroid abnormalities; stabilize before interpreting confounded endocrine results. Nature+1NatureManagement of hypertensive crisis: British and Irish ...nice org ukNATIONAL INSTITUTE FOR HEALTH AND CLINICAL ... |
| Resistant hypertension | Primary aldosteronism, renal disease, renovascular disease, obstructive sleep apnea, and medication/substance contributors | Screen for primary aldosteronism regardless of potassium concentration and systematically assess common coexisting causes. AHA Journals+2AHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...AHA JournalsResistant Hypertension: Detection, Evaluation, and ...jaccResistant Hypertension: An Overview of Evaluation and Treatment |
| Episodic or clinically suspicious catecholamine-excess phenotype | Pheochromocytoma/paraganglioma | Measure plasma and/or urinary metanephrines and arrange urgent specialty-directed evaluation. Nature+1NatureManagement of hypertensive crisis: British and Irish ...nice org ukNATIONAL INSTITUTE FOR HEALTH AND CLINICAL ... |
Before testing
Exclude modifiable mimics of resistant hypertension
Correct removable pressure-raising exposures and volume contributors before attributing uncontrolled blood pressure to a rare disorder.
Perform a structured reconciliation of prescription drugs, over-the-counter agents, supplements, recreational drugs, alcohol, and dietary exposures. Important causes include NSAIDs including COX-2 inhibitors, sympathomimetic decongestants and anorectics, cocaine, amphetamines, oral contraceptive hormones, adrenal steroid hormones, erythropoietin, cyclosporine, tacrolimus, licorice-containing products, and supplements containing ginseng, yohimbine, ma huang, or bitter orange. jaccjaccResistant Hypertension: An Overview of Evaluation and Treatment
Assess sodium exposure, extracellular-volume status, kidney disease, and adequacy of diuretic therapy. Excess sodium intake, volume retention from kidney disease, and inadequate diuresis can maintain apparent resistant hypertension and should be corrected in parallel with etiologic testing. jaccjaccResistant Hypertension: An Overview of Evaluation and Treatment
Actively assess obesity, diabetes, and obstructive sleep apnea in resistant hypertension. Obstructive sleep apnea is a common secondary cause associated with resistant hypertension, and its coexistence does not exclude renal, renovascular, or endocrine causes. AHA Journals+2AHA Journals2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ ...AHA JournalsResistant Hypertension: Detection, Evaluation, and ...jaccResistant Hypertension: An Overview of Evaluation and Treatment
Document NSAID, decongestant, stimulant, hormonal, corticosteroid, calcineurin-inhibitor, erythropoietin, and supplement exposure at each resistant-hypertension assessment. jaccjaccResistant Hypertension: An Overview of Evaluation and Treatment
Treat volume overload and optimize diuretic strategy before labeling blood pressure as pharmacologically refractory. jaccjaccResistant Hypertension: An Overview of Evaluation and Treatment
Use sleep-symptom assessment and formal sleep evaluation when obstructive sleep apnea is suspected clinically. AHA Journals+1AHA Journals2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ ...jaccResistant Hypertension: An Overview of Evaluation and Treatment
| Contributor | Examples | Clinical action |
|---|---|---|
| Medication-related blood-pressure elevation | NSAIDs, COX-2 inhibitors, sympathomimetics, oral contraceptives, corticosteroids, erythropoietin, cyclosporine, tacrolimus jaccjaccResistant Hypertension: An Overview of Evaluation and Treatment | Stop, substitute, or minimize the implicated exposure when clinically feasible; reassess blood pressure response. jaccjaccResistant Hypertension: An Overview of Evaluation and Treatment |
| Substance or supplement exposure | Cocaine, amphetamines, excess alcohol, licorice, ginseng, yohimbine, ma huang, bitter orange jaccjaccResistant Hypertension: An Overview of Evaluation and Treatment | Obtain a nonjudgmental exposure history and discontinue the causative product. jaccjaccResistant Hypertension: An Overview of Evaluation and Treatment |
| Sodium and volume excess | Excess sodium intake, kidney-disease-associated volume retention, inadequate diuretic therapy jaccjaccResistant Hypertension: An Overview of Evaluation and Treatment | Correct sodium and volume contributors while evaluating kidney disease. jaccjaccResistant Hypertension: An Overview of Evaluation and Treatment |
| Sleep-disordered breathing | Obstructive sleep apnea AHA Journals+1AHA Journals2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ ...jaccResistant Hypertension: An Overview of Evaluation and Treatment | Pursue sleep-focused evaluation when symptoms or resistant hypertension indicate risk. AHA Journals+1AHA Journals2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ ...jaccResistant Hypertension: An Overview of Evaluation and Treatment |
Targeted workup
Match testing to the most actionable etiologic branch
Use clinical phenotype and initial kidney, urine, endocrine, and sleep findings to sequence confirmatory testing.
Renal parenchymal disease is the most common medical cause of secondary hypertension in resistant-hypertension evaluations. Abnormal renal function, urine microscopy, or urine albumin-to-creatinine ratio should direct the next diagnostic step toward kidney disease rather than an isolated endocrine workup. Nature+1NatureManagement of hypertensive crisis: British and Irish ...jaccResistant Hypertension: An Overview of Evaluation and Treatment
Consider renovascular disease when the overall clinical setting suggests renal arterial disease, particularly in resistant hypertension. Renal artery stenosis is among the common identifiable causes in this setting; renal artery and kidney imaging should be directed by clinical suspicion rather than used as a universal screen. Nature+1NatureManagement of hypertensive crisis: British and Irish ...jaccResistant Hypertension: An Overview of Evaluation and Treatment
Primary aldosteronism is a high-priority, treatment-changing diagnosis. It occurs in approximately 5% to 10% of all hypertension and about 20% of resistant hypertension, and the 2025 AHA/ACC guideline recommends screening adults with resistant hypertension regardless of whether hypokalemia is present. AHA JournalsAHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...
Use the plasma aldosterone-to-renin ratio as the screening test for primary aldosteronism in patients with hypertension, including those without hypokalemia. A positive screen generally requires confirmation of inappropriate aldosterone secretion with a suppression test such as saline infusion or fludrocortisone suppression before subtype-directed management. Nature+1NaturePrimary Aldosteronism Diagnosis and Management | Endocrinology | Clinical Sciences | Health sciences | Topics | Nature IndexAHA JournalsRenin Ratio Cutoff for Primary Aldosteronism | Hypertension
If primary aldosteronism is confirmed, obtain adrenal imaging for anatomy but do not rely on CT or MRI alone to establish functional laterality; adrenal vein sampling is the reference standard for localization. NatureNaturePrimary Aldosteronism Diagnosis and Management | Endocrinology | Clinical Sciences | Health sciences | Topics | Nature Index
In confirmed primary aldosteronism with an adrenal adenoma, perform dexamethasone suppression testing to assess for cortisol co-secretion. endocrineendocrinePrimary Aldosteronism
Order plasma and/or urinary metanephrines for suspected pheochromocytoma/paraganglioma; pursue Cushing syndrome testing only when the clinical phenotype supports it. NatureNatureManagement of hypertensive crisis: British and Irish ...
Use thyroid testing as part of severe-hypertension assessment and evaluate overt hypo- or hyperthyroidism as potential contributors when results are abnormal. Nature+1NatureManagement of hypertensive crisis: British and Irish ...ScienceDirectRenal Hypertension - an overview
Primary aldosteronism
Primary aldosteronism should not be limited to the classic hypokalemic phenotype. Bilateral adrenal hyperplasia accounts for approximately two-thirds of cases, while about one-third have unilateral aldosterone overproduction from an aldosterone-producing adenoma, less often unilateral hyperplasia, and rarely adrenal carcinoma. AHA JournalsAHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...
Refer for multidisciplinary endocrine, radiology, and surgical evaluation once biochemical testing supports primary aldosteronism and a patient is a potential procedural candidate. The key management decision is functional laterality: unilateral disease supports laparoscopic adrenalectomy, whereas bilateral disease supports medical mineralocorticoid receptor antagonism. Nature+1NaturePrimary Aldosteronism Diagnosis and Management | Endocrinology | Clinical Sciences | Health sciences | Topics | Nature IndexendocrinePrimary Aldosteronism
Use aldosterone, renin, and potassium testing to screen for primary aldosteronism in hypertension under the 2025 Endocrine Society recommendation. endocrine+1endocrineEndocrine Society guideline calls for increased screening for common cause of high blood pressure | Endocrine SocietyendocrinePrimary Aldosteronism
Screen patients with resistant hypertension even if serum potassium is normal. AHA JournalsAHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...
Recognize that targeted treatment is associated with improved kidney and cardiovascular outcomes. AHA JournalsAHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...
Cause-directed care
Link diagnosis to definitive treatment and follow-up
The value of testing is highest when the result changes a durable intervention, not simply the antihypertensive drug count.
For primary aldosteronism, treatment selection follows subtype. Laparoscopic adrenalectomy is the preferred definitive therapy for unilateral aldosterone-producing adenoma and often cures or markedly improves hypertension; bilateral disease is treated medically with mineralocorticoid receptor antagonists. The Endocrine Society suggests spironolactone over alternative medical therapy for patients receiving primary-aldosteronism-specific treatment. Nature+1NaturePrimary Aldosteronism Diagnosis and Management | Endocrinology | Clinical Sciences | Health sciences | Topics | Nature IndexendocrinePrimary Aldosteronism
Use specialist referral early for suspected primary aldosteronism, pheochromocytoma/paraganglioma, Cushing syndrome, or renovascular hypertension because testing and treatment require technical interpretation and, in selected cases, specialized procedures. AHA Journals+1AHA Journals2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ...nice org ukNATIONAL INSTITUTE FOR HEALTH AND CLINICAL ...
Follow treatment response using blood pressure, serum potassium when mineralocorticoid excess or antagonism is relevant, and kidney function during management of kidney disease or mineralocorticoid receptor antagonist therapy. In primary aldosteronism, reassess blood-pressure control and biochemical abnormalities after medical therapy or adrenalectomy because cure is not universal even after treatment of unilateral disease. Nature+1NaturePrimary Aldosteronism Diagnosis and Management | Endocrinology | Clinical Sciences | Health sciences | Topics | Nature IndexendocrinePrimary Aldosteronism
Use adrenal vein sampling rather than anatomical imaging alone when accurate lateralization is required before unilateral adrenalectomy. NatureNaturePrimary Aldosteronism Diagnosis and Management | Endocrinology | Clinical Sciences | Health sciences | Topics | Nature Index
Add dexamethasone suppression testing when primary aldosteronism coexists with an adrenal adenoma. endocrineendocrinePrimary Aldosteronism
Refer suspected pheochromocytoma/paraganglioma promptly for specialty evaluation and surgical planning after biochemical assessment. Nature+1NatureManagement of hypertensive crisis: British and Irish ...nice org ukNATIONAL INSTITUTE FOR HEALTH AND CLINICAL ...
References
- 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ ... — www.ahajournals.org · www.ahajournals.org
- 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ ... — www.ahajournals.org · www.ahajournals.org
- Resistant Hypertension: Detection, Evaluation, and ... — www.ahajournals.org · www.ahajournals.org
- Resistant Hypertension: Diagnosis, Evaluation, and ... — www.ahajournals.org · www.ahajournals.org
- Management of hypertensive crisis: British and Irish ... — www.nature.com · www.nature.com
- Primary Aldosteronism Diagnosis and Management | Endocrinology | Clinical Sciences | Health sciences | Topics | Nature Index — www.nature.com · www.nature.com
- Recognize, Monitor, Treat: A Comprehensive Approach to Improving Resistant Hypertension Care — www.jacc.org · www.jacc.org
- Resistant Hypertension: An Overview of Evaluation and Treatment — www.jacc.org · www.jacc.org
- Investigating Endogenous Hypercortisolism Prevalence in a U.S. Population With Resistant Hypertension: MOMENTUM Rationale and Design — www.jacc.org · www.jacc.org
- Cardiac Phenotypes in Secondary Hypertension: JACC State-of-the-Art Review — www.jacc.org · www.jacc.org
- Spectrum of Hyperaldosteronism, Opportunities for Diagnosis — www.acpjournals.org · www.acpjournals.org
- Evaluations of secondary hypertension and laboratory data in the elderly population — www.sciencedirect.com · www.sciencedirect.com
- Evaluation and Management of Secondary Hypertension — www.sciencedirect.com · www.sciencedirect.com
- Renal Hypertension - an overview — www.sciencedirect.com · www.sciencedirect.com
- Review Diagnosis and treatment of primary aldosteronism — www.sciencedirect.com · www.sciencedirect.com
- Diagnosing endocrine hypertension: a practical approach — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- Diagnosis and treatment of primary aldosteronism: ... — onlinelibrary.wiley.com · onlinelibrary.wiley.com
- Endocrine Society guideline calls for increased screening for common cause of high blood pressure | Endocrine Society — www.endocrine.org · www.endocrine.org
- Primary Aldosteronism — www.endocrine.org · www.endocrine.org
- NATIONAL INSTITUTE FOR HEALTH AND CLINICAL ... — www.nice.org.uk · www.nice.org.uk
- Prevalence and Risk Factors for Secondary Hypertension ... — www.ahajournals.org · www.ahajournals.org
- Primary Aldosteronism | Circulation — www.ahajournals.org · www.ahajournals.org
- Clinical Management of Primary Aldosteronism: An Update — www.ahajournals.org · www.ahajournals.org
- Renin Ratio Cutoff for Primary Aldosteronism | Hypertension — www.ahajournals.org · www.ahajournals.org